Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Bristol-Myers Squibb

Bristol-Myers Squibb Contributes $20,000 to Girl Scouts’ STEM Education Program

stem-girls-1Trenton, NJ, November 5, 2016 — Girl Scouts introduces girls of every age to science, technology, engineering, and math (STEM) experiences relevant to everyday life.  That’s right — it’s more than cookies.

Whether they’re discovering how a car’s engine runs, how to manage finances, learning to code, building an app, or exploring careers in STEM fields, girls are fast-forwarding into the future.

However, without local community support, Girl Scouts’ STEM programs would not be able to reach as far or as wide. Continue reading

HINJ Honors Four at Life Sciences Celebration 2015: Rep. Lance, Dr. Nils Lonberg, Deborah Brown and David Knowlton

hinj_logo_high_resNew Brunswick, NJ, October 30, 2015 ― The HealthCare Institute of New Jersey (HINJ) this morning honored four for their contributions in public service, life sciences research, patient advocacy and health care policy.  The awards were presented at HINJ’s Life Sciences Celebration 2015, which was held at the Wyndham Garden Trenton.

The recipients of HINJ’s 2015 honors were:

  • The Honorable Bob Franks Public Service Award:  HINJ presented the Honorable Bob Franks Public Service Award — named in honor of the late former U.S. Congressman and HINJ President and Chief Executive Officer Bob Franks — to U.S. Representative Leonard Lance (R-NJ-7) for his leadership in protecting patients and scientific research and the advancement of global human health.  Mr. Lance, a member of the House Committee on Energy and Commerce, played a key leadership role in passage of the House’s 21st Century Cures Act (H.R. 6) in July 2015. Continue reading